2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3 Purity > 98.0% (GC) Ensitrelvir (S-217622) Intermediate COVID-19

Lus piav qhia luv luv:

Lub npe tshuaj: 2,4,5-Trifluorobenzyl Bromide

CAS: 157911-56-3 Nr

Purity:> 98.0% (GC)

Tsos: Xim tsis muaj xim rau lub teeb daj ntshiab kua

Intermediate of Ensitrelvir (S-217622), COVID-19

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chemical Properties:

Tshuaj npe 2,4,5-Trifluorobenzyl Bromide
Synonyms 1-(Bromomethyl)-2,4,5-trifluorobenzene
CAS Nr 157911-56-3
CAT Number Qauv TSIS MUAJ: RF-PI1505
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C7H4BrF3
Molecular Luj 225.01 Nws
Flash Point 75 ℃
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Colorless rau lub teeb daj ntshiab kua
Purity / Analysis Method > 98.0% (GC)
Moisture (KF) ≤0.50%
Lub ntiajteb txawj nqus (20/20) 1.714-1.719 Nws
Refractive Index (N20/D) 1.505-1.509 Nws
Tag nrho cov impurities <2.00%
Infrared Spectrum Raws li tus qauv
Test Standard Enterprise Standard
Kev siv Pharmaceutical Intermediates

Pob & Cia:

Pob: Lub raj mis, 25kg / chim, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.

Qhov zoo:

1

FAQ:

Daim ntawv thov:

2,4,5-Trifluorobenzyl Bromide (CAS: 157911-56-3) feem ntau yog siv hauv kev lag luam kws tshuaj ua tshuaj nruab nrab.2,4,5-Trifluorobenzyl Bromide yog ib qho tseem ceeb nruab nrab ntawm cov synthesis ntawm Sitagliptin (CAS: 486460-32-6).2,4,5-Trifluorobenzyl Bromide kuj yog ib qho tseem ceeb nruab nrab ntawm Ensitrelvir (S-217622).Ensitrelvir, tshuaj kho rau COVID-19, yog 3CL protease inhibitor tsim los ntawm kev tshawb fawb sib koom ntawm Hokkaido University thiab Shionogi.SARS-CoV-2 muaj ib qho enzyme hu ua 3CL protease, uas yog qhov tseem ceeb rau kev rov ua dua ntawm tus kab mob.Ensitrelvir suppresses replication ntawm SARS-CoV-2 los ntawm kev xaiv inhibiting 3CL protease.

Sau koj cov lus ntawm no thiab xa tuaj rau peb